Biotech investing funds companies developing drugs, therapies, and medical technologies. Investors buy shares or fund startups, betting on clinical trials and regulatory approvals. Success brings breakthroughs and high returns; failure risks losses. It suits venture capitalists, institutional funds, and individuals seeking growth, while patients benefit from new treatments.
Get alerts when this topic surges in newsletters. Free to start.
Sign up freeExplore more trends:Trending Topics ·This Month's Top Topics ·AI Trends ·Business Trends ·Finance Trends ·Technology Trends